U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07717346) titled 'A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease' on July 08.
Brief Summary: An open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease
Study Start Date: May 06
Study Type: INTERVENTIONAL
Condition:
Hailey Hailey Disease
Skin Diseases
Lesion Skin
Intervention:
BIOLOGICAL: KB111
KB111 is a replication-defective, non-integrating herpes simplex virus (HSV-1)-based vector encoding functional, full-length human ATP2C1 protein combined with a gel for topical application.
Recruitment Status: RECRUITING
Sponsor: Krystal Bi...